Skip to main content
Clinical Trials/NCT06579547
NCT06579547RecruitingNot Applicable

Single-center Prospective Comparison of Diagnostic Performance of Deep-learning Agumented UTE/ZTE MRI Sequences and Standard-of-care Low Dose CT for Rheumatologic Patients With Musculoskeletal Disease

Roman Guggenberger1 site in 1 country100 target enrollmentStarted: August 1, 2024Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Sponsor
Enrollment
100
Locations
1
Primary Endpoint
Visibility of trabecular bone

Study Overview

Brief Summary

The goal of this clinical trial is to determine how effectively bone structures of the human skeleton can be visualized using Deep Learning (DL) augmented Magnetic Resonance Imaging (MRI) in individuals with inflammatory and degenerative joint changes, compared to Computed Tomography (CT). MRI is a technique that operates without the use of X-rays. The main question it aims to answer is:

  1. Can DL MRI accurately depict bone structures as well as CT?
  2. Can DL MRI be used as an alternative to CT to avoid exposure to X-rays in the future?

Researchers will compare DL MRI scans to CT scans to see if DL MRI can effectively replace CT in visualizing bone structures without the use of radiation.

Participants will:

  1. Undergo MRI scans of their skeletal system that will then be processed using DL.
  2. Undergo CT scans of the same body region for comparison purposes.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Diagnostic
Masking
Single (Outcomes Assessor)

Masking Description

The radiologists who perform the readout will be blinded to the reference low dose CT scan to avoid being primed for certain bony anatomy and pathology by evaluating the low dose CT first. The reference low dose CT scan will be read in a separate session.

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Referral for a clinically indicated MRI examination of the musculoskeletal system to assess inflammatory and degenerative joint changes.
  • •Willingness to sign the informed consent form.
  • •No contraindications for a CT examination (e.g., claustrophobia).

Exclusion Criteria

  • •No signed informed consent form.
  • •Patients under 18 years of age.
  • •Pregnant women.
  • •The calculated effective dose of the CT examination exceeds 5 mSv.

Outcomes

Primary Outcomes

Visibility of trabecular bone

Time Frame: one day (day of MRI and CT examination)

Scale from 1 to 4 1. hardly visible 2. diagnostic with some artifact 3. diagnostic with little artifact 4. very good depiction A higher score means better image quality.

Visibility of cortical bone

Time Frame: one day (day of MRI and CT examination)

Scale from 1 to 4 1. hardly visible 2. diagnostic with some artifact 3. diagnostic with little artifact 4. very good depiction A higher score means better image quality.

Visibility of soft tissue calcifications

Time Frame: one day (day of MRI and CT examination)

Scale from 1 to 4 1. hardly visible 2. diagnostic with some artifact 3. diagnostic with little artifact 4. very good depiction A higher score means better image quality.

Contrast to noise ratio

Time Frame: one day (day of MRI and CT examination)

Average signal of erosion minus average signal of adjacent healthy bone, divided by the average background signal A higher score means better contrast of erosions when standardized for healthy adjacent bone and against the background.

Total score for bone erosions

Time Frame: one day (day of MRI and CT examination)

Each bone is scored separately. The scale is 0-10, based on the proportion of eroded bone compared to the "assessed bone volume," judged on all available images: 0: no erosion; 1: 1-10% of bone eroded; 2: 11-20%, etc. For long bones, the "assessed bone volume" is from the articular surface (or its best estimated position if absent) to a depth of 1 cm, while in carpal/tarsal bones it is the whole bone. Example of bone list for hands: carpal bones, distal radius, distal ulna, metacarpal bases; metacarpophalangeal, MCP, joints: metacarpal head, phalangeal base; maximum points: 230. A higher score means more bone erosions. Note: The total score will vary according to body area imaged, this will be taken into account in the final analysis.

Total score for joint space narrowing

Time Frame: one day (day of MRI and CT examination)

0: no narrowing, 1: focal or mild (\< 33%), 2: moderate (34-66%), 3: moderate to severe (67-99%), 4: ankylosis A higher score means more joint space narrowing. Note: The total score will vary according to body area imaged, this will be taken into account in the final analysis.

Signal to noise ratio

Time Frame: one day (day of MRI and CT examination)

Average signal of erosion divided by the average background signal A higher score means better contrast of erosions against the background.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Roman Guggenberger
Sponsor Class
Other
Responsible Party
Sponsor Investigator
Principal Investigator

Roman Guggenberger

Senior Physician (Leitender Arzt)

University of Zurich

Study Sites (1)

Loading locations...

Similar Trials